The FDA has approved bemotrizinol, a new chemical filter, marking the first significant addition to sunscreen ingredients in decades. Bemotrizinol protects against both UVA and UVB rays, an area where many existing sunscreen options have limitations. This ingredient has been available overseas for many years. It is described as lightweight and doesn’t leave a white cast, addressing common concerns with mineral sunscreens. Bemotrizinol joins zinc oxide and titanium dioxide as ingredients considered ‘generally recognized as safe and effective’ (GRASE) by the FDA. Unlike many current options, bemotrizinol provides protection against UVA rays, which are deep-penetrating and contribute to aging and cancer risk. It’s a large molecule, reducing absorption into the body and minimizing potential environmental impact. Bemotrizinol is also photostable, meaning it resists breakdown from sunlight, and can improve the stability of other filters in sunscreen formulations. Extensive research and testing, including human safety studies, animal toxicology, and environmental assessments, support its safety. The approval process involved a full FDA new-drug-caliber review with a comprehensive safety dossier. Prior to this approval, the U.S. historically lagged behind other countries in sunscreen chemistry, relying on a limited menu of approximately 16 approved filters. Dermatologists believe this approval is timely, given that fewer than 60 percent of American adults consistently use sunscreen. The approval represents a meaningful advance in sun protection, alongside continued adherence to fundamental sun safety practices such as broad-spectrum SPF 30 or higher, adequate application, and reapplication.